期刊文献+

乌司他丁治疗重症烧伤脓毒症的效果观察 被引量:8

Clinical effects of ulinastatin in patients with severe burn sepsis
下载PDF
导出
摘要 目的通过乌司他丁治疗重症烧伤脓毒症患者的疗效观察,探讨其中的可能机制。方法将62例重症烧伤脓毒症患者随机分为治疗组(n=31)和对照组(n=31),对照组采取经典治疗方案,包括早期复苏,抗感染治疗,营养支持对症治疗,血液净化治疗及呼吸机治疗等,治疗组在经典治疗的基础上加用乌司他丁治疗,观察比较两组治疗前后呼吸(R)、心率(HR)、体温(T)、白细胞计数(WBC)及中性粒细胞比例(N)等临床指标和动静脉血气分析、肌酐(Cr)、尿素氮(BUN)、谷丙转氨酶(ALT)、谷草转氨酶(AST)、乳酸脱氢酶(LDH)、肌酸激酶同工酶MB(CK-MB)等血液生化指标的变化。同时比较两组28 d病死率。结果治疗后两组患者R、HR、T、WBC及中性粒细胞比例较前明显下降(P<0.05),两组患者血浆ALT、AST、Cr、BUN、LDH、CK-MB均下降,治疗组各指标改善更加明显(P<0.05),两组机体摄氧率及氧合指数增加(P<0.05),治疗组增加更加显著(P<0.05),与对照组相比28 d病死率明显下降(P<0.05)。结论乌司他丁可有效抑制重症烧伤脓毒症患者的炎症反应,改善患者器官功能及机体摄氧功能,具有良好的临床效果。 Aim To analyze the efficiency of ulinastatin(UTI)in patients with severe burn sepsis syndrome.Methods 62 patients with severe burn sepsis syndrome were randomly divided into treatment group(n=31)and control group(n=31).In the treatment group,patients had Ulinastatin 400 000 IU twice every day for 7 days.The classical treatment including early resuscitation,antibiotic therapy,mechanical ventilation therapy and blood purification was given to two groups.Temperature,respiration,heart rate and white blood cell,neutrocyte percent,the mortality rate on 28 days and other plasma biochemistry indexes were determined before the treatment and after the treatment.Results After the treatment,the levels of temperature,respiration,heart rate and white blood cell,neutrocyte percent were significantly decreased in two groups(P〈0.05),but the decreases of the treatment group were more marked(P〈0.05),The ratio and index of oxygen increased.Plasma alanine amino transferase,aspartate amino transferase,blood ureanitrogen,lactate dehydrogenase and MB isoenzyme of creatine kinase were decreased in two groups after the treatment(P〈0.05),but the decreases of all these plasma biochemistria indexes were more marked in UTI group(P〈0.05).The treatment group has lower mortality rate on 28 days(P〈0.05).Conclusion UTI has beneficial effects in patients with severe burn sepsis syndrome.
出处 《安徽医药》 CAS 2010年第11期1340-1342,共3页 Anhui Medical and Pharmaceutical Journal
基金 2009年安徽省卫生厅科研资金资助(No09A067)
关键词 乌司他丁 烧伤 脓毒症 ulinastatin burn sepsis
  • 相关文献

参考文献7

  • 1Fong Y,Tracey KJ,Moldawer LL,et al.Antibodies to cachet-in/TNF reduce IL-1 p and IL-6 appearance during lethal bacte-remia[J].J EXp Med,1989,170:1627-33.
  • 2Bemard GR,Vincent JL,Laterre PF,et al.Efficacy and safety of recombinant human activated protein C for severe sepsis[J].N Engl J Med,2001,344(10):699-709.
  • 3Masuda T,Sato K,Noda,et al.Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion[J].Crit Care Med,2003,31(7):1987-92.
  • 4邵义明,张良清,邓烈华,姚华国.乌司他丁对全身炎症反应综合征的治疗作用[J].中国危重病急救医学,2005,17(4):228-230. 被引量:154
  • 5王玉巧,马玉龙,张跃斌,刘辉,张科东,陈月芬.乌司他丁治疗严重脓毒症的临床效果观察[J].宁夏医学杂志,2008,30(4):330-331. 被引量:3
  • 6Ito K,Mizutani A,Klm S,et al.Effect of Ulinastatin,a human urinary trypsin inhibitor,Oil the oleic acid-induced acute lung injury in rats via the inhibition of activated leukocytes[J].Injury,2005,36(3):387-94.
  • 7邢金燕,孙运波,傅培荣,韩小宁.乌司他丁对脓毒症患者氧摄取的影响[J].山东医药,2005,45(7):54-55. 被引量:1

二级参考文献17

  • 1王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准(经庐山’95全国危重病急救医学学术会讨论通过)[J].中国危重病急救医学,1995,7(6):346-347. 被引量:1422
  • 2Levy MM,Fink MP,Marshall JC,et al 2001SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med,2003,31(11):1250~1256.
  • 3Mervyn S,Vincenzo DS,Domenico V,et al.Multiorgan failure is an adaptive,endocrine-mediated,metabolic response to overwhelming systemic inflammation The Lancet,2004,364(9433):545~548.
  • 4Westpha M,Daudel F,Bone HG,et al.New approach to an ovine model of hypodynamic endotoxaemia.Eur J Anaesthesiol,2004,21(8):625~631.
  • 5Ono S,Ichikura T,Mochizuki H.The pathogenesis of the systemic inflammatory response syndrome and compensatory antiinflammatory response syndrome following surgical stress[J].Nippon Geka Gakkai Zasshi,2003,104:499-505.
  • 6Levels J H,Lemaire L C,van den Ende A E,et al.Lipid compo-sition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure[J].Crit Care Med,2003,31:1647-1653.
  • 7Matsukawa H,Hara A,Ito T,et al.Continuous arterial infusion of protease inhibitor with supplementory therapy for the patients with severe acute pancreatitis-clinical effect of arterial injection of ulinastatin[J].Nippon Shokakibyo Gakkai Zasshi,1998,95:1229-1234.
  • 8Bone R C,Balk R A,Cerra F B,et al.The ACCP/SCCM consensus conference on sepsis and organ failure[J].Chest,1992,101:1644-1655.
  • 9Masuda T,Sato K,Noda C,et al.Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion[J].Crit Care Med,2003,31:1987-1992.
  • 10Levy MM, Fink MP, Marshall JC, et al. International sepsis definitions conference. 2001 SCCM/ ESICM/ ACCP/ ACCP/ ATS/ SIS international sepsis definitions cofernce [ J ]. Intensive Care Med, 2003,29 (4) :530 -534.

共引文献155

同被引文献95

引证文献8

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部